Request a document copy: Cost‑Efectiveness Analysis of Herpes Zoster Vaccination in 50‑ to 85‑Year‑Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live‑Attenuated Vaccine

all files (of this document) in restricted access
the file(s) you requested
Cancel